BIO Announces Selection of 2009 Presenting Companies for 8th Annual BIO Investor Forum.Industry Leaders to Discuss Investment Opportunities and Approaches to Sustaining and Leveraging Innovation WASHINGTON -- The Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
The BIO Investor Forum will feature over 110 company presentations from select late-stage private and emerging public biotech companies. Companies were chosen through a competitive screening process with input by an advisory committee comprised of members from top-tier firms focused on investing and banking in the life sciences industry. The advisory committee includes: * Benjamin R. Bowen, Ph.D., Rodman & Renshaw, LLC * Howard Furst, M.D., Deerfield Management * John R. Leone, Paul Capital * Graeme Martin, Ph.D., Takeda Research Investments, Inc. * Evan McCulloch, CFA (Computer Fraud and Abuse Act of 1986) Signed into law in 1986, the CFA was a significant step forward in criminalizing unauthorized access to computer systems and networks. The Act applies to "federal interest computers" that include any system used by the U.S. , Franklin Templeton Investments Franklin Resources Inc. NYSE: BEN is an investment firm originally founded in New York in 1947 as Franklin Distributors, Inc. It is listed on the NYSE under the ticker BEN as in Benjamin Franklin, whom founder Charlie Johnson admired. * Oleg Nodelman, Biotechnology Value Fund, LP * Heather Preston, M.D., TPG Biotech * Bryan E. Roberts, Ph.D., Venrock * Mark Schoenebaum, M.D., Deutsche Bank AG * Chris Swindle, Wedbush PacGrow Life Sciences * Paul Wagner, Ph.D., CFA, RCM Capital Management, LLC "The BIO Investor Forum will feature senior management from biotech companies that are poised for leadership status in highly competitive areas of therapeutic innovation," said Alan Eisenberg, executive vice president, Emerging Companies & Business Development at BIO. "The companies selected to speak in 2009 are creating value through development-stage programs with near-term clinical catalysts. These are the companies that will help drive the investment and deal making in the life sciences sector and global innovation in healthcare." The following companies will present at the 8th Annual BIO Investor Forum: Acologix, Inc. Advanced Life Sciences (ADLS ADLS Auckland District Law Society (New Zealand) ADLS Advanced Disaster Life Support ADLS Aeronautical Data Link System ADLS Activities of Daily Living Skills (developmental disabilities) ) Advaxis Inc. (ADXS) Affectis Pharmaceuticals AG Alchemia Ltd. (ACL See access control list. 1. ACL - Access Control List. 2. ACL - Association for Computational Linguistics. 3. ACL - A Coroutine Language. A Pascal-based implementation of coroutines. ["Coroutines", C.D. ) Allon Therapeutics Inc. (NPC 1. (complexity) NPC - NP-complete. 2. (architecture) NPC - Next Program Counter. ) Amira Pharmaceuticals, Inc. Anadys Pharmaceuticals Inc. (ANDS) Aradigm Corporation (ARDM) Arete Therapeutics Athersys Inc. (ATHX) Bayhill Therapeutics, Inc. BioSante Pharmaceuticals, Inc. (BPAX) Biotec Pharmacon ASA Asa (ā`sə), in the Bible, king of Judah, son and successor of Abijah. He was a good king, zealous in his extirpation of idols. When Baasha of Israel took Ramah (a few miles N of Jerusalem), Asa bought the help of Benhadad of Damascus and (BIOTEC) BrainCells, Inc. Calistoga Pharmaceuticals Catalyst Biosciences, Inc. Celladon Ceregene, Inc. Chimerix, Inc. Cleveland BioLabs Inc. (CBLI) CoLucid Pharmaceuticals Complete Genomics, Inc. Curis, Inc. (CRIS) Cyclacel Pharmaceuticals Inc. (CYCC CYCC Canadian Youth Climate Coalition ) Cylene Pharmaceuticals, Inc. EGEN EGEN Electricity Generation , Inc. Elixir Pharmaceuticals, Inc. Endocyte, Inc. Epeius Biotechnologies Corp. Essentialis, Inc. ExonHit Therapeutics S.A. (ALEHT) GenVec, Inc. (GNVC) GlobeImmune, Inc. ImmunoVaccine Technologies Inc. ImmuPharma plc (IMM IMM See: International Monetary Market ) Inimex Pharmaceuticals, Inc. Inotek Pharmaceuticals Corp. Inovio Biomedical Corp. (INO) Intarcia Therapeutics, Inc. Intrexon Corporation KAI Pharmaceuticals, Inc. LifeCycle Pharma A/S (LCP) LigoCyte Pharmaceuticals, Inc. Locus Pharmaceuticals, Inc. MacroGenics, Inc. Marinus Pharmaceuticals, Inc. MDRNA, Inc. (MRNA) MethylGene Inc. (MYG) Micromet Inc. (MITI) NeurAxon Inc. Newron Pharmaceuticals S.p.A. (NWRN NWRN Northwestern (weather reports) ) NovaBay Pharmaceuticals Inc. (NBY) Novalar Pharmaceuticals, Inc. Novavax, Inc. (NVAX NVAX Nvidia Audio Enumerator ) Novelos Therapeutics Inc. (NVLT NVLT Novelos Therapeutics, Inc (stock symbol) NVLT Night Vision Low-Tech (US Army program) ) Nuon Therapeutics, Inc. Oncolytics Biotech Inc. (ONCY) OncoMed Pharmaceuticals, Inc. Osteologix Inc. (OLGX) ParinGenix, Inc. Peptimmune, Inc. Plexxikon Inc. Portola Pharmaceuticals, Inc. Presidio Pharmaceuticals, Inc. Profectus Biosciences, Inc. PTC (PTC, Needham, MA, www.ptc.com) Long a world leader in mechanical computer-aided design, manufacturing and engineering software, PTC, through acquisitions and reorganization, has transformed itself into a leading provider of Internet-based B2B solutions for discrete manufacturers. Therapeutics QuatRx Pharmaceuticals Raptor Pharmaceuticals Corp. (RPTP RPTP Receptor Protein Tyrosine Phosphatase ) Regado Biosciences, Inc. Resolvyx Pharmaceuticals, Inc. SARcode Corporation Somaxon Pharmaceuticals, Inc. (SOMX) Stromedix, Inc. Supernus Pharmaceuticals, Inc. Targacept, Inc. (TRGT) Transcept Pharmaceuticals, Inc. (TSPT) Tranzyme Pharma, Inc. Trubion Pharmaceuticals Inc. (TRBN) VirtualScopics, Inc. (VSCP) VLST Corporation, Inc. WaferGen Bio-Systems Inc. (WGBS) Wilex AG (WL6) Zelos Therapeutics, Inc. ZIOPHARM Oncology Inc. (ZIOP) The BIO Investor Forum will also host panels for industry leaders to weigh strategies for efficient product development, evaluating therapeutic investment and accessing capital and resources. Highlights for this year's conference include plenary sessions on sustaining biotech innovation in light of healthcare reform, as well as forecasting key industry and investment catalysts for 2010. Therapeutic workshops will address areas of dynamic pipeline growth including prostate cancer, influenza, autoimmune disease and personalized medicine; and this year's business roundtables will offer the buyer's perspective on today's IPO (Initial Public Offering) The first time a company offers shares of stock to the public. While not a computer term per se, many founders, employees and insiders of computer companies have found this acronym more exciting than any tech term they ever heard. candidates and prospects, the insider's view on designing clinical trials that increase deal value, and new deal structures designed to reduce M&A risk. The BIO Investor Forum is a national investor conference featuring leading private and emerging public companies. The meeting attracts sophisticated healthcare venture capital and public market investors and research analysts. In addition, the BIO Investor Forum draws business development executives from leading global pharmaceutical and biotechnology companies. To learn more about the BIO Investor Forum, including registration and program information, please visit http://investorforum.bio.org/. Registration is complimentary for qualified investors. Upcoming BIO Events BIO Investor Forum October 28-29, 2009 San Francisco, CA Advanced Business Development Course October 30, 2009 Vienna, Austria BIO Europe International Partnering Conference November 2-4, 2009 Vienna, Austria Pacific Rim Summit on Industrial Biotechnology and Bioenergy November 8-11, 2009 Honolulu, HI About BIO BIO represents more than 1,200 biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world's largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion